Abstract
Background Asymmetrical enlargement of the nasolacrimal canal and nasolacrimal duct in the absence of associated neoplasm is uncommon. A dilemma in proper management is encountered because the subject is not well discussed in the medical literature. Design Case series. Participants Three patients with abnormal enlargement of the nasolacrimal canal on computed tomography (CT) are analyzed. Two patients had a history of intermittent acquired dacryocystocele, whereas one had no associated lacrimal disorder. Intervention To relieve their obstructive symptoms, one patient was treated with lacrimal probing and silicone intubation, and the other patient was treated with dacryocystorhinostomy. The third patient, who was asymptomatic, elected observation alone. Main outcome measures Anteroposterior diameters of the nasolacrimal canal were measured from the CT scans of these cases and compared with normative data derived from radiologic and anatomic studies. Results The maximal anteroposterior diameters of the nasolacrimal canals from these patients were 12.5, 15.4, and 15.1 mm, all well above the upper range of normal (8–10 mm). These enlarged nasolacrimal canals were not associated with any neoplastic process. Follow-up CT scans showed no change in size of the nasolacrimal canal. Conclusion Nasolacrimal canal enlargement may occur without neoplasia of the lacrimal sac or nasolacrimal duct. In the absence of other features suggestive of neoplasia, appropriate management is aimed at treatment of lacrimal obstructive symptoms, if present, and serial CT scans. Open biopsy of the nasolacrimal duct is not necessary in asymptomatic patients with stable CT findings.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.